Syncromune, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through May 11, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Aug 21, 2025 · D/A | May 11, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $144,828,791 | $144,828,791 | $0 |
| Reported amount sold | $111,828,793 | $144,828,791 | $32,999,998 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001231919-25-000158 · Later SEC source: 0001231919-26-000472
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $144,828,791
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $144,828,791
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001231919-26-000472D/A · May 11, 2026 · BiotechnologyOffering: $144,828,791Sold: $144,828,791
Compared with 0001231919-25-000158:
- Reported amount sold: $111,828,793 → $144,828,791
-
0001231919-25-000158D/A · Aug 21, 2025 · BiotechnologyOffering: $144,828,791Sold: $111,828,793